Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · IEX Real-Time Price · USD
1.270
-0.010 (-0.78%)
At close: Apr 16, 2024, 4:00 PM
1.340
+0.070 (5.51%)
After-hours: Apr 16, 2024, 6:21 PM EDT

Ikena Oncology Stock Forecast

IKNA's stock price has decreased by -73.5% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Ikena Oncology stock have an average target of 10.67, with a low estimate of 8.00 and a high estimate of 13. The average target predicts an increase of 740.16% from the current stock price of 1.27.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8.00 $10.67 $11 $13
Change +529.92% +740.16% +766.14% +923.62%

Analyst Ratings

The average analyst rating for Ikena Oncology stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 222211
Buy 222222
Hold 000000
Sell 000000
Strong Sell 000000
Total 444433

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +766.14% Mar 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$11
Strong Buy Maintains $11 +766.14% Mar 12, 2024
Wedbush
Wedbush
Buy
Reiterates
$8
Buy Reiterates $8 +529.92% Jan 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +766.14% Jan 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$18$11
Strong Buy Maintains $18$11 +766.14% Nov 9, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
7.14M
from 9.16M
Decreased by -22.05%
Revenue Next Year
8.67M
from 7.14M
Increased by 21.43%
EPS This Year
-1.58
from -1.63
EPS Next Year
-1.37
from -1.58
Year 2019202020212022202320242025202620272028
Revenue
13.75M9.19M30.99M15.62M9.16M7.14M8.67M13.77M38.52M79.66M
Revenue Growth
--33.15%237.01%-49.59%-41.35%-22.05%21.43%58.82%179.75%106.80%
EPS
-6.35-16.00-1.22-1.90-1.63-1.58-1.37-1.27-1.35-0.78
EPS Growth
----------
No. Analysts -----76664
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 14.7M 21.0M 42.0M 157.5M 176.4M
Avg 7.1M 8.7M 13.8M 38.5M 79.7M
Low n/a n/a n/a n/a 13.7M

Revenue Growth

Revenue Growth 20242025202620272028
High
60.5%
194.1%
384.4%
1,043.8%
357.9%
Avg
-22.1%
21.4%
58.8%
179.7%
106.8%
Low - - - -
-64.4%

EPS Forecast

EPS 20242025202620272028
High -1.50 -1.16 -1.03 -0.24 -0.28
Avg -1.58 -1.37 -1.27 -1.35 -0.78
Low -1.66 -1.44 -1.35 -2.17 -1.23

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.